53 results
8-K
EX-10.1
TPST
Tempest Therapeutics Inc
21 Jun 22
Departure of Directors or Certain Officers
7:31am
; (xxvii) debt levels; (xxviii) operating profit or net operating profit; (xxix) workforce diversity; (xxx) growth of net income or operating income
PRE 14A
agog32g2wjm9r
22 Apr 22
Preliminary proxy
4:01pm
424B3
gmdns68q2cr
11 May 21
Prospectus supplement
5:19pm
8-K
EX-2.1
zupe 4ueu7xsb99
29 Mar 21
Tempest and Millendo Announce Proposed Merger Agreement
7:29am
425
EX-2.1
qqsihrubpne1w19btnct
29 Mar 21
Business combination disclosure
7:27am
8-K
61if92
28 Jan 21
Cost Associated with Exit or Disposal Activities
8:01am
8-K
EX-10.1
bsv77shjkx te5id
28 Jan 21
Cost Associated with Exit or Disposal Activities
8:01am
8-K
EX-99.1
jp0bgv060285v4zioks
5 Jan 21
Millendo Therapeutics Provides Pipeline and Business Update
9:08am